Profile: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,401.00GBp
11:37am EDT
Change (% chg)

1.00p (+0.07%)
Prev Close
1,400.00p
Open
1,401.00p
Day's High
1,412.50p
Day's Low
1,395.00p
Volume
9,369,792
Avg. Vol
9,621,424
52-wk High
1,645.00p
52-wk Low
1,296.50p

Search Stocks
GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. The Company operates in two segments: Pharmaceuticals and Vaccines, and Consumer Healthcare. The Pharmaceuticals segment develops and makes medicines to treat a range of acute and chronic diseases. Its human immunodeficiency virus (HIV) business is managed through ViiV Healthcare. GSK's Vaccines has a portfolio of over 30 paediatric, adolescent, adult travel vaccines. GSK's Established Products Portfolio includes over 50 off-patent products, as well as its branded generics business and other local products. The Consumer Healthcare business develops and markets products in four categories, such as wellness, oral health, nutrition and skin health. Its brands include Sensodyne, Panadol, Horlicks, Polident, Paradontax, Tums, ENO, NiQuitin/Nicorette, Abreva, Zovirax and Aquafresh. It operates in the United Kingdom, the United States, Belgium and China.

Company Address

GlaxoSmithKline PLC

980 Great West Road
BRENTFORD     TW8 9GS
P: +4420.80475000
F: +4420.80477807

Company Web Links

Search Stocks